Multi-kinase inhibitor 1
Multi-kinase inhibitor 1 is a potent multi-kinase inhibitor. Multi-kinase inhibitor 1 has the potential for diseases or disorders associated with abnormal or deregulated tyrosine kinase activity, particularly diseases associated with the activity of PDGF-R, c-Kit and Bcr-abl[1].
Product Specifications
CAS Number
778274-97-8
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Bcr-Abl; c-Kit; PDGFR
Type
Reference compound
Related Pathways
Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/multi-kinase-inhibitor-1.html
Purity
99.05
Solubility
DMSO : 100 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
O=C(NCCO)C1=CC=C(C2=NC=NC(NC3=CC=C(OC(F)(F)F)C=C3)=C2)C=C1
Molecular Formula
C20H17F3N4O3
Molecular Weight
418.37
Precautions
H302, H315, H319, H335
References & Citations
[1]Qiang Ding, et al. Novel compounds and compositions as protein kinase inhibitors. WO2004089286A2.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, protect from light)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
PDGFR
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
CD106 / VCAM1 (1.4C3), CF405S conjugate, 0.1mg/mL
CD45 / LCA (2B11 + PD7/26), CF594 conjugate, 0.1mg/mL
